Your browser doesn't support javascript.
loading
Diagnosis of Helicobacter pylori infection: serology vs. urea breath test.
Imperial, Miguel; Tan, Kennard; Fjell, Chris; Chang, Yin; Krajden, Mel; Kelly, Michael T; Morshed, Muhammad.
Afiliación
  • Imperial M; Department of Pathology and Lab Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tan K; BC Women's and Children's Hospital, Vancouver, British Columbia, Canada.
  • Fjell C; Lifelabs, Surrey, British Columbia, Canada.
  • Chang Y; Department of Pathology and Lab Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Krajden M; Fraser Health Authority, Surrey, British Columbia, Canada.
  • Kelly MT; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Morshed M; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Microbiol Spectr ; : e0108424, 2024 Sep 27.
Article en En | MEDLINE | ID: mdl-39329478
ABSTRACT
The objective of the study was to ascertain an optimal Helicobacter pylori diagnostic strategy using population-level laboratory data comparing the performance of serology against urea breath test (UBT). H. pylori diagnostic test results for serology and UBT from two laboratories over a 12-year period (2006-20017) were extracted, linked, and analyzed. A subset of this population underwent both methods of testing within days of each other, enabling a direct comparison of the two methods. The average prevalence of H. pylori positivity was 21.3% by serology and 17.5% by UBT. There were 2,612 individuals who had serology performed first, followed by UBT within 14 days. For this subset, the sensitivity of serology compared with UBT was 96.5% with a specificity of 79.2%. The negative predictive value for serology was 98.4%. Contrary to various recent clinical guidelines, the data show that serology still has utility as a sensitive enough test to be used as an initial H. pylori screening test in a lower prevalence population. Negative serology can be used with confidence to rule out active infection, whereas a positive serology could be followed up with a UBT or a similar performing test such as stool antigen to differentiate active from past infection. For population-based diagnostic recommendations, such a strategy may be ideal since serology generally costs less than UBT and may be combined with a blood draw being done for other diagnostic tests. Continuing to offer serology increases options for patients and may provide economic benefits for single-payer health care systems or health maintenance organizations. IMPORTANCE This study compares the performance of serology with urea breath test in the diagnosis of Helicobacter pylori in a population-level data set and mimics a head-to-head direct comparison as the study population had both tests performed within 2 weeks of each other. This provides new information supporting the use of serology in a diagnostic algorithm. There are several instances where serology could be preferable to patients to rule out disease, despite some guidelines suggesting serology should not be used.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos